2-[4-(2H-1,3-benzodioxol-5-yl)-1-(2-methylphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(oxolan-2-yl)methyl]acetamide
Chemical Structure Depiction of
2-[4-(2H-1,3-benzodioxol-5-yl)-1-(2-methylphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(oxolan-2-yl)methyl]acetamide
2-[4-(2H-1,3-benzodioxol-5-yl)-1-(2-methylphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(oxolan-2-yl)methyl]acetamide
Compound characteristics
Compound ID: | V007-6456 |
Compound Name: | 2-[4-(2H-1,3-benzodioxol-5-yl)-1-(2-methylphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-[(oxolan-2-yl)methyl]acetamide |
Molecular Weight: | 596.71 |
Molecular Formula: | C33 H32 N4 O5 S |
Smiles: | Cc1ccccc1n1c2c(C(c3ccc4c(c3)OCO4)SCC(N2CC(NCC2CCCO2)=O)=O)c(c2ccccc2)n1 |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 4.9399 |
logD: | 4.9399 |
logSw: | -4.5864 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 79.965 |
InChI Key: | CBVOJKRLHFGPBH-UHFFFAOYSA-N |